June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Progressive aniridia-associated keratopathy phenotype in a Polish cohort – therapeutic implications
Author Affiliations & Notes
  • Neil S Lagali
    Ophthalmology, Linkoping University, Linkoping, Sweden
  • Bogumil Wowra
    Ophthalmology Department II, Medical University of Silesia, Katowice, Poland
  • Dariusz Dobrowolski
    Ophthalmology Department II, Medical University of Silesia, Katowice, Poland
  • Tor Utheim
    Department of Medical Biochemistry, University of Oslo, Oslo, Norway
  • Edward Wylegala
    Ophthalmology Department II, Medical University of Silesia, Katowice, Poland
  • Per Fagerholm
    Ophthalmology, Linkoping University, Linkoping, Sweden
  • Footnotes
    Commercial Relationships   Neil Lagali, None; Bogumil Wowra, None; Dariusz Dobrowolski, None; Tor Utheim, None; Edward Wylegala, None; Per Fagerholm, None
  • Footnotes
    Support  Support was received from the Aniridia Norway foundation.
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 4811. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Neil S Lagali, Bogumil Wowra, Dariusz Dobrowolski, Tor Utheim, Edward Wylegala, Per Fagerholm; Progressive aniridia-associated keratopathy phenotype in a Polish cohort – therapeutic implications. Invest. Ophthalmol. Vis. Sci. 2017;58(8):4811.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate the central corneal phenotype in patients with aniridia-associated keratopathy (AAK) in relation to age and disease severity.

Methods : 37 subjects (68 eyes) with congenital aniridia aged 7-75 years, were examined at the University of Silesia, Poland. Examinations included slit lamp biomicroscopy grading, Cochet-Bonnet esthesiometry, and in vivo confocal microscopy (IVCM) of the central and paracentral cornea.

Results : AAK severity increased with age (P < 0.001) with logarithmic progression and onset of visual axis involvement typically between 20 – 30 years of age. 30% of subjects had an asymmetric AAK grade across eyes. Corneal epithelium in early stage AAK shifted to mixed and conjunctival phenotype in later stages. Goblet cells were more prevalent in later stages but were found in only half of late stage eyes. Subbasal nerve and mature dendritic cell presence diminished, sensitivity declined, inflammatory cell infiltration increased, and blood and lymph vessels increased with progressing AAK. Epithelial cysts were present in 30% of eyes regardless of age while Bowman’s layer abnormalities were detected in about 10% of eyes.

Conclusions : AAK spares the central epithelium, nerves, and immune privileged status of the cornea in an early stage, indicating a possible therapeutic window for halting progression. Phenotypic changes assessed by IVCM in progressing AAK, such as neurotrophic deficit, invasion of inflammatory cells and lymph vessels, suggest impaired wound healing and activated immune response and may in part explain the generally poor outcome following corneal surgery in subjects with aniridia.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×